tetano
Editor, Senior Moderator
Blood Rev
. 2020 Dec 8;100785.
doi: 10.1016/j.blre.2020.100785. Online ahead of print.
The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis
Nanyang Liu[SUP] 1 [/SUP], Tingting Zhang[SUP] 2 [/SUP], Lina Ma[SUP] 1 [/SUP], Huiqing Zhang[SUP] 1 [/SUP], Huichan Wang[SUP] 1 [/SUP], Wei Wei[SUP] 2 [/SUP], Hui Pei[SUP] 1 [/SUP], Hao Li[SUP] 3 [/SUP]
Affiliations
Abstract
The 2019 coronavirus disease (COVID-19) has become a global pandemic. Several studies report that ABO blood group polymorphism may be related to COVID-19 susceptibility and clinical outcomes; however, the results are controversial. We conducted a systematic review and meta-analysis to investigate whether ABO blood groups are associated with increased COVID-19 morbidity and mortality. A total of 715 articles were retrieved from seven databases. Ten articles were selected for meta-analysis after removal of duplicates and two levels of screenings. Overall, individuals with blood group A [odds ratio (OR) = 1.33, 95% confidence interval (CI) 1.14 to 1.56] and B (OR = 1.06, 95% CI 1.00 to 1.13) had a substantially higher risk of COVID-19, whereas this was not the case for blood group AB (OR = 1.07, 95% CI 0.88 to 1.30). Individuals with blood group O was not prone to develop the disease (OR = 0.71, 95% CI 0.60 to 0.84). Moreover, the risk of COVID-19 was significantly associated with the Rh-positive blood group (OR = 1.22, 95% CI 0.99 to 1.50). A meta-analysis of 5 studies suggested that blood group A was associated with a significantly increased risk of COVID-19 mortality (OR = 1.25, 95% CI 1.02 to 1.52). Mild publication bias was found in the included studies. This systematic review and meta-analysis indicated that blood groups A and B may be risk factors for COVID-19, whereas the blood group O appears to be protective. Blood group A may be related to unfavourable outcomes. Further rigorous and high-quality research evidence is needed to confirm this association.
Keywords: 2019 coronavirus disease; ABO blood group; Anti-A antibody; Virus.
. 2020 Dec 8;100785.
doi: 10.1016/j.blre.2020.100785. Online ahead of print.
The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis
Nanyang Liu[SUP] 1 [/SUP], Tingting Zhang[SUP] 2 [/SUP], Lina Ma[SUP] 1 [/SUP], Huiqing Zhang[SUP] 1 [/SUP], Huichan Wang[SUP] 1 [/SUP], Wei Wei[SUP] 2 [/SUP], Hui Pei[SUP] 1 [/SUP], Hao Li[SUP] 3 [/SUP]
Affiliations
- PMID: 33309392
- DOI: 10.1016/j.blre.2020.100785
Abstract
The 2019 coronavirus disease (COVID-19) has become a global pandemic. Several studies report that ABO blood group polymorphism may be related to COVID-19 susceptibility and clinical outcomes; however, the results are controversial. We conducted a systematic review and meta-analysis to investigate whether ABO blood groups are associated with increased COVID-19 morbidity and mortality. A total of 715 articles were retrieved from seven databases. Ten articles were selected for meta-analysis after removal of duplicates and two levels of screenings. Overall, individuals with blood group A [odds ratio (OR) = 1.33, 95% confidence interval (CI) 1.14 to 1.56] and B (OR = 1.06, 95% CI 1.00 to 1.13) had a substantially higher risk of COVID-19, whereas this was not the case for blood group AB (OR = 1.07, 95% CI 0.88 to 1.30). Individuals with blood group O was not prone to develop the disease (OR = 0.71, 95% CI 0.60 to 0.84). Moreover, the risk of COVID-19 was significantly associated with the Rh-positive blood group (OR = 1.22, 95% CI 0.99 to 1.50). A meta-analysis of 5 studies suggested that blood group A was associated with a significantly increased risk of COVID-19 mortality (OR = 1.25, 95% CI 1.02 to 1.52). Mild publication bias was found in the included studies. This systematic review and meta-analysis indicated that blood groups A and B may be risk factors for COVID-19, whereas the blood group O appears to be protective. Blood group A may be related to unfavourable outcomes. Further rigorous and high-quality research evidence is needed to confirm this association.
Keywords: 2019 coronavirus disease; ABO blood group; Anti-A antibody; Virus.